Wim Pinxten
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wim Pinxten has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Kris Dierickx
KU Leuven
8 shared publications - Noémie Aubert Bonn
University of Manchester, Department of Computer Science, Manchester, United Kingdom
7 shared publications Herman Nys
Centre for Biomédical Ethics and Law, K. U. Leuven, BE-3000 Leuven, Belgium
6 shared publications- Carl Lachat
Department of Food Technology, Safety and Health, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium
2 shared publications - Pascal Borry
Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care KU Leuven Leuven Belgium
2 shared publications - Raffaella Ravinetto
Institute of Tropical Medicine
2 shared publications
Latest Publications
- Open Access
- 3 March 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (5) , 101341
Research on the genome of microorganisms: ethical considerations and recommendations regarding the incidental bystander sequencing of human genetic material
- 3 March 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (5) , 101341
Open AccessResearch on the genome of microorganisms: ethical considerations and recommendations regarding the incidental bystander sequencing of human genetic material
- Open Access
- 24 September 2022
- Published by Springer Nature in BMC Research Notes
- Vol. 15 (1) , 1-6
The failure of success: four lessons learned in five years of research on research integrity and research assessments
In the past 5 years, we captured the perspectives from a broad array of research stakeholders to better understand the impact that current approaches to success and research assessment may have on the integrity and the quality of research. Here, we translate our findings in four actions that are urgently needed to foster better research. First, we need to address core research structures to overcome systemic problems of the research enterprise; second, we must realign research assessments to value elements that advance and strengthen science; third, we need to remodel, diversify, and secure research careers; and finally, we need to unite and coordinate efforts for change.
- 24 September 2022
- Published by Springer Nature in BMC Research Notes
- Vol. 15 (1) , 1-6
Open AccessThe failure of success: four lessons learned in five years of research on research integrity and research assessments
In the past 5 years, we captured the perspectives from a broad array of research stakeholders to better understand the impact that current approaches to success and research assessment may have on the integrity and the quality of research. Here, we translate our findings in four actions that are urgently needed to foster better research. First, we need to address core research structures to overcome systemic problems of the research enterprise; second, we must realign research assessments to value elements that advance and strengthen science; third, we need to remodel, diversify, and secure research careers; and finally, we need to unite and coordinate efforts for change.
- Open Access
- 14 December 2021
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 787342
Crowd Funding for Orphan Drugs: The Case of Baby Pia
Medical crowdfunding is a relatively new strategy to obtain access to orphan drugs. The case of Baby Pia, a Belgian girl with SMA type 1 for whom in 2018 more than $ 2.1 million was raised to get her treated with Zolgensma®, illustrates well the potential power of medical crowdfunding. But apart from the success in raising money, the case is also of particular importance for the ethical issues it brings to the surface as related to justice, equity, power imbalances, responsibility, accountability, indebtedness and privacy.
- 14 December 2021
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 787342
Open AccessCrowd Funding for Orphan Drugs: The Case of Baby Pia
Medical crowdfunding is a relatively new strategy to obtain access to orphan drugs. The case of Baby Pia, a Belgian girl with SMA type 1 for whom in 2018 more than $ 2.1 million was raised to get her treated with Zolgensma®, illustrates well the potential power of medical crowdfunding. But apart from the success in raising money, the case is also of particular importance for the ethical issues it brings to the surface as related to justice, equity, power imbalances, responsibility, accountability, indebtedness and privacy.
- Open Access
- 11 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0243664
Advancing science or advancing careers? Researchers’ opinions on success indicators
The way in which we assess researchers has been under the radar in the past few years. Critics argue that current research assessments focus on productivity and that they increase unhealthy pressures on scientists. Yet, the precise ways in which assessments should change is still open for debate. We circulated a survey with Flemish researchers to understand how they work, and how they would rate the relevance of specific indicators used in research assessments. We found that most researchers worked far beyond their expected working schedule. We also found that, although they spent most of their time doing research, respondents wished they could dedicate more time to it and spend less time writing grants and performing other activities such as administrative duties and meetings. When looking at success indicators, we found that indicators related to openness, transparency, quality, and innovation were perceived as highly important in advancing science, but as relatively overlooked in career advancement. Conversely, indicators which denoted of prestige and competition were generally rated as important to career advancement, but irrelevant or even detrimental in advancing science. Open comments from respondents further revealed that, although indicators which indicate openness, transparency, and quality (e.g., publishing open access, publishing negative findings, sharing data, etc.) should ultimately be valued more in research assessments, the resources and support currently in place were insufficient to allow researchers to endorse such practices. In other words, current research assessments are inadequate and ignore practices which are essential in contributing to the advancement of science. Yet, before we change the way in which researchers are being assessed, supporting infrastructures must be put in place to ensure that researchers are able to commit to the activities that may benefit the advancement of science.
- 11 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0243664
Open AccessAdvancing science or advancing careers? Researchers’ opinions on success indicators
The way in which we assess researchers has been under the radar in the past few years. Critics argue that current research assessments focus on productivity and that they increase unhealthy pressures on scientists. Yet, the precise ways in which assessments should change is still open for debate. We circulated a survey with Flemish researchers to understand how they work, and how they would rate the relevance of specific indicators used in research assessments. We found that most researchers worked far beyond their expected working schedule. We also found that, although they spent most of their time doing research, respondents wished they could dedicate more time to it and spend less time writing grants and performing other activities such as administrative duties and meetings. When looking at success indicators, we found that indicators related to openness, transparency, quality, and innovation were perceived as highly important in advancing science, but as relatively overlooked in career advancement. Conversely, indicators which denoted of prestige and competition were generally rated as important to career advancement, but irrelevant or even detrimental in advancing science. Open comments from respondents further revealed that, although indicators which indicate openness, transparency, and quality (e.g., publishing open access, publishing negative findings, sharing data, etc.) should ultimately be valued more in research assessments, the resources and support currently in place were insufficient to allow researchers to endorse such practices. In other words, current research assessments are inadequate and ignore practices which are essential in contributing to the advancement of science. Yet, before we change the way in which researchers are being assessed, supporting infrastructures must be put in place to ensure that researchers are able to commit to the activities that may benefit the advancement of science.
- 2 February 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (7) , e28923
Neuroblastoma: The basis for cure in limited‐resource settings
Background: Neuroblastoma (NB) contributes the most to the mortality of childhood malignancies worldwide. The disease spectrum is heterogenous and the management complex and costly, especially in advanced disease or disease with adverse biology. In low‐ and middle‐income countries (LMICs) the majority of NB presents in advanced stages. Therefore, with limited resources and poor prognosis the treatment of NB is often not a priority. The aim of the study was to evaluate the research activities and perceptions of the management of NB that determine the research and treatment approaches in LMICs.Methods: Data were sourced from https://www.clinicaltrials.gov/ identifying NB trials open to LMIC. Abstracts on NB research presented at the International Society for Paediatric Oncology (SIOP) Congresses between 2014 and 2020 were evaluated according to income status. An online survey evaluating medical views on NB in LMICs and the effect on the management was conducted. Descriptive analysis was done. Where appropriate categorical association between covariates was assessed using the Pearson chi‐square (χ2) test or Fishers exact test.Results: There were 15/562 (2.7%) trials open to LMIC. Only six of 138 (4.3%) LMIC participated in NB trials. Of the 688 abstracts presented between 2014 and 2020 at the SIOP International Congress on NB as primary subject, 297 (42.7%) were from LMICs. Only two were from low‐income countries (LICs). Sixty‐one countries responded to the NB survey. Positive views towards NB management were present when treatment was based on a national protocol, the availability of trimodal or advanced treatment options were present, and when a balance of metastatic or local disease were treated.Conclusion: Management of NB in LMICs should include increased advocacy and research as well as implementation of national management strategies.
- 2 February 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (7) , e28923
Neuroblastoma: The basis for cure in limited‐resource settings
Background: Neuroblastoma (NB) contributes the most to the mortality of childhood malignancies worldwide. The disease spectrum is heterogenous and the management complex and costly, especially in advanced disease or disease with adverse biology. In low‐ and middle‐income countries (LMICs) the majority of NB presents in advanced stages. Therefore, with limited resources and poor prognosis the treatment of NB is often not a priority. The aim of the study was to evaluate the research activities and perceptions of the management of NB that determine the research and treatment approaches in LMICs.Methods: Data were sourced from https://www.clinicaltrials.gov/ identifying NB trials open to LMIC. Abstracts on NB research presented at the International Society for Paediatric Oncology (SIOP) Congresses between 2014 and 2020 were evaluated according to income status. An online survey evaluating medical views on NB in LMICs and the effect on the management was conducted. Descriptive analysis was done. Where appropriate categorical association between covariates was assessed using the Pearson chi‐square (χ2) test or Fishers exact test.Results: There were 15/562 (2.7%) trials open to LMIC. Only six of 138 (4.3%) LMIC participated in NB trials. Of the 688 abstracts presented between 2014 and 2020 at the SIOP International Congress on NB as primary subject, 297 (42.7%) were from LMICs. Only two were from low‐income countries (LICs). Sixty‐one countries responded to the NB survey. Positive views towards NB management were present when treatment was based on a national protocol, the availability of trimodal or advanced treatment options were present, and when a balance of metastatic or local disease were treated.Conclusion: Management of NB in LMICs should include increased advocacy and research as well as implementation of national management strategies.
- Open Access
Advancing science or advancing careers? Researchers’ opinions on success indicators
The way in which we assess researchers has been under the radar in the past few years. Critics argue that current research assessments focus on productivity and that they increase unhealthy pressures on scientists. Yet, the precise ways in which assessments should change is still open for debate. We circulated a survey with Flemish researchers to understand how they work, and how they would rate the relevance of specific indicators used in research assessments. We found that most researchers worked far beyond their expected working schedule. We also found that, although they spent most of their time doing research, respondents wished they could dedicate more time to it and spend less time writing grants and performing other activities such as administrative duties and meetings. When looking at success indicators, we found that indicators related to openness, transparency, quality, and innovation were perceived as highly important in advancing science, but as relatively overlooked in career advancement. Conversely, indicators which denoted of prestige and competition were generally rated as important to career advancement, but irrelevant or even detrimental in advancing science. Open comments from respondents further revealed that, although indicators which indicate openness, transparency, and quality (e.g., publishing open access, publishing negative findings, sharing data, etc.) should ultimately be valued more in research assessments, the resources and support currently in place were insufficient to allow researchers to endorse such practices. In other words, current research assessments are inadequate and ignore practices which are essential in contributing to the advancement of science. Yet, before we change the way in which researchers are being assessed, supporting infrastructures must be put in place to ensure that researchers are able to commit to the activities that may benefit the advancement of science. Submission history: The first version of this manuscript was submitted to PLOS ONE on 27th June 2020. Revisions after peer-review were submitted on 4th October 2020 and 20th November 2020.
Open AccessAdvancing science or advancing careers? Researchers’ opinions on success indicators
The way in which we assess researchers has been under the radar in the past few years. Critics argue that current research assessments focus on productivity and that they increase unhealthy pressures on scientists. Yet, the precise ways in which assessments should change is still open for debate. We circulated a survey with Flemish researchers to understand how they work, and how they would rate the relevance of specific indicators used in research assessments. We found that most researchers worked far beyond their expected working schedule. We also found that, although they spent most of their time doing research, respondents wished they could dedicate more time to it and spend less time writing grants and performing other activities such as administrative duties and meetings. When looking at success indicators, we found that indicators related to openness, transparency, quality, and innovation were perceived as highly important in advancing science, but as relatively overlooked in career advancement. Conversely, indicators which denoted of prestige and competition were generally rated as important to career advancement, but irrelevant or even detrimental in advancing science. Open comments from respondents further revealed that, although indicators which indicate openness, transparency, and quality (e.g., publishing open access, publishing negative findings, sharing data, etc.) should ultimately be valued more in research assessments, the resources and support currently in place were insufficient to allow researchers to endorse such practices. In other words, current research assessments are inadequate and ignore practices which are essential in contributing to the advancement of science. Yet, before we change the way in which researchers are being assessed, supporting infrastructures must be put in place to ensure that researchers are able to commit to the activities that may benefit the advancement of science. Submission history: The first version of this manuscript was submitted to PLOS ONE on 27th June 2020. Revisions after peer-review were submitted on 4th October 2020 and 20th November 2020.
- Open Access
Rethinking success, integrity, and culture in research (Part 2) — A multi-actor qualitative study on problems of science
Background: Research misconduct and questionable research practices have been the subject of increasing attention in the past few years. But despite the rich body of research available, few empirical works provide the perspectives of non-researcher stakeholders. Methods: To capture some of the forgotten voices, we conducted semi-structured interviews and focus groups with policy makers, funders, institution leaders, editors or publishers, research integrity office members, research integrity community members, laboratory technicians, researchers, research students, and former-researchers who changed career to inquire on the topics of success, integrity, and responsibilities in science. We used the Flemish biomedical landscape as a baseline to be able to grasp the views of interacting and complementary actors in a system setting. Results: Given the breadth of our results, we divided our findings in a two-paper series with the current paper focusing on the problems that affect the quality and integrity of science. We first discovered that perspectives on misconduct, including the core reasons for condemning misconduct, differed between individuals and actor groups. Beyond misconduct, interviewees also identified numerous problems which affect the integrity of research. Issues related to personalities and attitudes, lack of knowledge of good practices, and research climate were mentioned. Elements that were described as essential for success (in the associate paper) were often thought to accentuate the problems of research climates by disrupting research cultures and research environments. Even though everyone agreed that current research climates need to be addressed, no one felt responsible nor capable of initiating change. Instead, respondents revealed a circle of blame and mistrust between actor groups. Conclusions: Our findings resonate with recent debates, and extrapolate a few action points which might help advance the discussion. First, we must tackle how research is assessed. Second, approaches to promote better science should be revisited: not only should they directly address the impact of climates on research practices, but they should also redefine their objective to empower and support researchers rather than to capitalize on their compliance. Finally, inter-actor dialogues and shared decision making are crucial to building joint objectives for change. Trial registration: osf.io/33v3m
Open AccessRethinking success, integrity, and culture in research (Part 2) — A multi-actor qualitative study on problems of science
Background: Research misconduct and questionable research practices have been the subject of increasing attention in the past few years. But despite the rich body of research available, few empirical works provide the perspectives of non-researcher stakeholders. Methods: To capture some of the forgotten voices, we conducted semi-structured interviews and focus groups with policy makers, funders, institution leaders, editors or publishers, research integrity office members, research integrity community members, laboratory technicians, researchers, research students, and former-researchers who changed career to inquire on the topics of success, integrity, and responsibilities in science. We used the Flemish biomedical landscape as a baseline to be able to grasp the views of interacting and complementary actors in a system setting. Results: Given the breadth of our results, we divided our findings in a two-paper series with the current paper focusing on the problems that affect the quality and integrity of science. We first discovered that perspectives on misconduct, including the core reasons for condemning misconduct, differed between individuals and actor groups. Beyond misconduct, interviewees also identified numerous problems which affect the integrity of research. Issues related to personalities and attitudes, lack of knowledge of good practices, and research climate were mentioned. Elements that were described as essential for success (in the associate paper) were often thought to accentuate the problems of research climates by disrupting research cultures and research environments. Even though everyone agreed that current research climates need to be addressed, no one felt responsible nor capable of initiating change. Instead, respondents revealed a circle of blame and mistrust between actor groups. Conclusions: Our findings resonate with recent debates, and extrapolate a few action points which might help advance the discussion. First, we must tackle how research is assessed. Second, approaches to promote better science should be revisited: not only should they directly address the impact of climates on research practices, but they should also redefine their objective to empower and support researchers rather than to capitalize on their compliance. Finally, inter-actor dialogues and shared decision making are crucial to building joint objectives for change. Trial registration: osf.io/33v3m
- Open Access
Rethinking success, integrity, and culture in research (part 1) — A multi-actor qualitative study on success in science
Background: Success shapes the life and careers of scientists. But success in science is difficult to define, let alone to translate in indicators that can be used for assessment. In the past few years, several groups expressed their dissatisfaction with the indicators currently used for assessing researchers. But given the lack of agreement on what should constitute success in science, most propositions remain unanswered. This paper aims to complement our understanding of success in science and to document areas of tension and conflict in research assessments. Methods: We conducted semi-structured interviews and focus groups with policy makers, funders, institution leaders, editors or publishers, research integrity office members, research integrity community members, laboratory technicians, researchers, research students, and former-researchers who changed career to inquire on the topics of success, integrity, and responsibilities in science. We used the Flemish biomedical landscape as a baseline to be able to grasp the views of interacting and complementary actors in a system setting. Results: Given the breadth of our results, we divided our findings in a two-paper series, with the current paper focusing on what defines and determines success in science. Respondents depicted success as a multi-factorial, context-dependent, and mutable factor. Success appeared to be an interaction between characteristics from the researcher (Who), research outputs (What), processes (How), and luck. Interviewees noted that current research assessments overvalued outputs but largely ignored the processes deemed essential for research quality and integrity. Interviewees sustained that we need a diversity of indicators to allow a balanced and diverse view of success; that assessments should not blindly depend on metrics but also value human input; that we must value quality over quantity; and that any indicators used must be transparent, robust, and valid. Conclusions: The objective of research assessments may be to encourage good researchers, to benefit society, or simply to advance science. Yet we show that current assessments fall short on each of these objectives. Open and transparent inter-actor dialogue is needed to understand what research assessments aim for and how they can best achieve their objective. Trial Registration: osf.io/33v3m
Open AccessRethinking success, integrity, and culture in research (part 1) — A multi-actor qualitative study on success in science
Background: Success shapes the life and careers of scientists. But success in science is difficult to define, let alone to translate in indicators that can be used for assessment. In the past few years, several groups expressed their dissatisfaction with the indicators currently used for assessing researchers. But given the lack of agreement on what should constitute success in science, most propositions remain unanswered. This paper aims to complement our understanding of success in science and to document areas of tension and conflict in research assessments. Methods: We conducted semi-structured interviews and focus groups with policy makers, funders, institution leaders, editors or publishers, research integrity office members, research integrity community members, laboratory technicians, researchers, research students, and former-researchers who changed career to inquire on the topics of success, integrity, and responsibilities in science. We used the Flemish biomedical landscape as a baseline to be able to grasp the views of interacting and complementary actors in a system setting. Results: Given the breadth of our results, we divided our findings in a two-paper series, with the current paper focusing on what defines and determines success in science. Respondents depicted success as a multi-factorial, context-dependent, and mutable factor. Success appeared to be an interaction between characteristics from the researcher (Who), research outputs (What), processes (How), and luck. Interviewees noted that current research assessments overvalued outputs but largely ignored the processes deemed essential for research quality and integrity. Interviewees sustained that we need a diversity of indicators to allow a balanced and diverse view of success; that assessments should not blindly depend on metrics but also value human input; that we must value quality over quantity; and that any indicators used must be transparent, robust, and valid. Conclusions: The objective of research assessments may be to encourage good researchers, to benefit society, or simply to advance science. Yet we show that current assessments fall short on each of these objectives. Open and transparent inter-actor dialogue is needed to understand what research assessments aim for and how they can best achieve their objective. Trial Registration: osf.io/33v3m
- Open Access
A decade of empirical research on research integrity: what have we (not) looked at?
In the past decades, increasing visibility of research misconduct scandals created momentum for discourses on research integrity to such an extent that the topic became a field of research itself. Yet, a comprehensive overview of research in the field is still missing. Here we describe methods, trends, publishing patterns, and impact of a decade of research on research integrity. To give a comprehensive overview of research on research integrity, we first systematically searched SCOPUS, Web of Science, and PubMed for relevant articles published in English between 2005 and 2015. We then classified each relevant article according to its topic, several methodological characteristics, its general focus and findings, and its citation impact. We included 986 articles in our analysis. We found that the body of literature on research integrity is growing in importance, and that the field is still largely dominated by non-empirical publications. Within the bulk of empirical records (N=342), researchers and students are most often studied, but other actors and the social context in which they interact, seem to be overlooked. The few empirical articles that examined determinants of misconduct found that problems from the research system (e.g., pressure, competition) were most likely to cause inadequate research practices. Paradoxically, the majority of empirical articles proposing approaches to foster integrity focused on techniques to build researchers’ awareness and compliance rather than techniques to change the research system. Our review highlights the areas, methods, and actors favoured in research on research integrity, and reveals a few blindspots. Involving non-researchers and reconnecting what is known to the approaches investigated may be the first step to generate executable knowledge that will allow us to increase the success of future approaches. A word from the authors: We find important to mention that this manuscript underwent peer review and was rejected from the following journals: PLOS ONE Submitted 19 th December 2017 Peer-review and rejection received 26 th June 2018. Journal of Science and Engineering Ethics (JSEE) Submitted 18 th August 2018 Peer-review response with major revision request received 9 th September 2019 Revision submitted 24 th October 218 Rejection received 27 th December 2018 We regret not having submitted this preprint before our first submission. Nonetheless, now after over one year in submission processes, we thought that we should make this manuscript and its data available as a pre-print before undergoing further submissions. In order to promote transparency however, we asked both journal whether anonymous reviews could be added alongside this pre-print to ensure that readers are informed of the issues that disqualified our manuscript. PLOS ONE agreed for us to share the anonymous reviews which are now available — together with our itemized changes and responses — in the ‘Online Resource 5 – Peer Review Report’. We thank the editors of the Journal of Science and Engineering Ethics and the integrity team of Springer Nature for thoroughly discussing our request, but unfortunately, given the closed peer review policy at Springer Nature, we were unable to provide information about the peer review from the Journal of Science and Engineering Ethics. We advise our readers to look at the peer-review and be aware of the challenges and limitations attached with our work. Of course, we welcome comments and contributions to make our work better. Sincerely, Noémie Aubert Bonn and Wim Pinxten
Open AccessA decade of empirical research on research integrity: what have we (not) looked at?
In the past decades, increasing visibility of research misconduct scandals created momentum for discourses on research integrity to such an extent that the topic became a field of research itself. Yet, a comprehensive overview of research in the field is still missing. Here we describe methods, trends, publishing patterns, and impact of a decade of research on research integrity. To give a comprehensive overview of research on research integrity, we first systematically searched SCOPUS, Web of Science, and PubMed for relevant articles published in English between 2005 and 2015. We then classified each relevant article according to its topic, several methodological characteristics, its general focus and findings, and its citation impact. We included 986 articles in our analysis. We found that the body of literature on research integrity is growing in importance, and that the field is still largely dominated by non-empirical publications. Within the bulk of empirical records (N=342), researchers and students are most often studied, but other actors and the social context in which they interact, seem to be overlooked. The few empirical articles that examined determinants of misconduct found that problems from the research system (e.g., pressure, competition) were most likely to cause inadequate research practices. Paradoxically, the majority of empirical articles proposing approaches to foster integrity focused on techniques to build researchers’ awareness and compliance rather than techniques to change the research system. Our review highlights the areas, methods, and actors favoured in research on research integrity, and reveals a few blindspots. Involving non-researchers and reconnecting what is known to the approaches investigated may be the first step to generate executable knowledge that will allow us to increase the success of future approaches. A word from the authors: We find important to mention that this manuscript underwent peer review and was rejected from the following journals: PLOS ONE Submitted 19 th December 2017 Peer-review and rejection received 26 th June 2018. Journal of Science and Engineering Ethics (JSEE) Submitted 18 th August 2018 Peer-review response with major revision request received 9 th September 2019 Revision submitted 24 th October 218 Rejection received 27 th December 2018 We regret not having submitted this preprint before our first submission. Nonetheless, now after over one year in submission processes, we thought that we should make this manuscript and its data available as a pre-print before undergoing further submissions. In order to promote transparency however, we asked both journal whether anonymous reviews could be added alongside this pre-print to ensure that readers are informed of the issues that disqualified our manuscript. PLOS ONE agreed for us to share the anonymous reviews which are now available — together with our itemized changes and responses — in the ‘Online Resource 5 – Peer Review Report’. We thank the editors of the Journal of Science and Engineering Ethics and the integrity team of Springer Nature for thoroughly discussing our request, but unfortunately, given the closed peer review policy at Springer Nature, we were unable to provide information about the peer review from the Journal of Science and Engineering Ethics. We advise our readers to look at the peer-review and be aware of the challenges and limitations attached with our work. Of course, we welcome comments and contributions to make our work better. Sincerely, Noémie Aubert Bonn and Wim Pinxten
- 10 September 2018
- Published by Elsevier in Advances in Nutrition
- Vol. 9 (6) , 671-687
Perspective: Consideration of Values When Setting Priorities in Nutrition Research: Guidance for Transparency
Nutrition research can guide interventions to tackle the burden of diet-related diseases. Setting priorities in nutrition research, however, requires the engagement of various stakeholders with diverse insights. Consideration of what matters most in research from a scientific, social, and ethical perspective is therefore not an automatic process. Systematic ways to explicitly define and consider relevant values are largely lacking. Here, we review existing nutrition research priority-setting exercises, analyze how values are reported, and provide guidance for transparent consideration of values while setting priorities in nutrition research. Of the 27 (n = 22 peer-reviewed manuscripts and 5 grey literature documents) studies reviewed, 40.7% used a combination of different methods, 59.3% described the represented stakeholders, and 49.1% reported on follow-up activities. All priority-setting exercises were led by research groups based in high-income countries. Via an iterative qualitative content analysis, reported values were identified (n = 22 manuscripts). Three clusters of values (i.e., those related to impact, feasibility, and accountability) were identified. These values were organized in a tool to help those involved in setting research priorities systematically consider and report values. The tool was finalized through an online consultation with 7 international stakeholders. The value-oriented tool for priority setting in nutrition research identifies and presents values that are already implicitly and explicitly represented in priority-setting exercises. It provides guidance to enable explicit deliberation on research priorities from an ethical perspective. In addition, it can serve as a reporting tool to document how value-laden choices are made during priority setting and help foster the accountability of stakeholders involved.
- 10 September 2018
- Published by Elsevier in Advances in Nutrition
- Vol. 9 (6) , 671-687
Perspective: Consideration of Values When Setting Priorities in Nutrition Research: Guidance for Transparency
Nutrition research can guide interventions to tackle the burden of diet-related diseases. Setting priorities in nutrition research, however, requires the engagement of various stakeholders with diverse insights. Consideration of what matters most in research from a scientific, social, and ethical perspective is therefore not an automatic process. Systematic ways to explicitly define and consider relevant values are largely lacking. Here, we review existing nutrition research priority-setting exercises, analyze how values are reported, and provide guidance for transparent consideration of values while setting priorities in nutrition research. Of the 27 (n = 22 peer-reviewed manuscripts and 5 grey literature documents) studies reviewed, 40.7% used a combination of different methods, 59.3% described the represented stakeholders, and 49.1% reported on follow-up activities. All priority-setting exercises were led by research groups based in high-income countries. Via an iterative qualitative content analysis, reported values were identified (n = 22 manuscripts). Three clusters of values (i.e., those related to impact, feasibility, and accountability) were identified. These values were organized in a tool to help those involved in setting research priorities systematically consider and report values. The tool was finalized through an online consultation with 7 international stakeholders. The value-oriented tool for priority setting in nutrition research identifies and presents values that are already implicitly and explicitly represented in priority-setting exercises. It provides guidance to enable explicit deliberation on research priorities from an ethical perspective. In addition, it can serve as a reporting tool to document how value-laden choices are made during priority setting and help foster the accountability of stakeholders involved.